Daniel N. Swisher, Jr
2019 - Jazz Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $560,000 |
|---|---|
| Option Awards | $1,506,379 |
| Salary | $667,308 |
| Stock Awards | $1,960,419 |
| Other | $13,302 |
| Total | $4,707,407 |
Swisher received $2M in stock awards, accounting for 42% of the total pay in 2019.
Swisher also received $560K in non-equity incentive plan, $1.5M in option awards, $667.3K in salary and $13.3K in other compensation.
Rankings
In 2019, Daniel N. Swisher, Jr's compensation ranked 2,396th out of 13,971 executives tracked by ExecPay. In other words, Swisher earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,396 out of 13,971 | 83rd |
Division Manufacturing | 867 out of 5,692 | 85th |
Major group Chemicals And Allied Products | 281 out of 2,189 | 87th |
Industry group Drugs | 226 out of 1,875 | 88th |
Industry Pharmaceutical Preparations | 166 out of 1,387 | 88th |
Pay ratio
| Daniel N. Swisher, Jr's Pay | $4,707,407 |
|---|---|
| Median Employee's Pay | $214,881 |
| Pay Ratio | 22to 1 |
In 2019, the annual total compensation of Daniel N. Swisher, Jr was $4,707,407.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $214,881.
The ratio of Daniel N. Swisher, Jr's pay to the pay of median employee was therefore 22 to one.
Swisher's colleagues
We found six more compensation records of executives who worked with Daniel N. Swisher, Jr at Jazz Pharmaceuticals in 2019.
2019
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2019
Robert Iannone
Jazz Pharmaceuticals
Executive Vice President, Research and Development
2019
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2019
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
2019
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2019
Neena Patil
Jazz Pharmaceuticals
Senior Vice President and GC
News
June 10, 2022
June 11, 2021
June 12, 2020
June 14, 2019